ImmunoGen Inc (IMGN)

[skitahoe]

It's still my belief that with information from presentations due between now and the end of the year we will see double digits this year. It won't have been a bad year if it only were to close near high's it's already achieved, but I believe it will do better than that.

I did by some April $7 calls on recent weakness and believe they should close well in the black by then.

When we see actual ASH data, I believe it will have some improvement over what's in the issued abstract because of added dose escalations, but what should drive IMGN much higher is information on IMGN853 in combination with other drugs which should be featured at the AACC/EORTC conference which I believe is held early December. That is my belief, it hasn't been announced yet to my knowledge.

Gary